This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
J&J's Ortho-McNeil Pharmaceutical is the new licensee for Axert (almotriptan malate tablet), a marketed migraine treatment developed by pharmaceutical company Almirall Prodesfarma. Ortho's rights cover the US and Canada.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?